Sailong Pharmaceutical: Legal Opinion of Beijing Kangda Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Sailong Pharmaceutical Group Co., Ltd.

SZSI · Sep 20

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.